Teladoc Health, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities.
Teladoc allows patients to see a licensed doctor at any time via a PC or mobile device, reducing the need to take time off from work. With Teladoc handling an estimated two million visits in 2018, the company still covers less than 1% of its potential market, the addressable market is about 1.25 billion doctor visits.
In 2018, CVS Health’s MinuteClinic and Teleadoc agreed to a three-year partnership so it could offering video visits to its customers through its CVS Pharmacy app.
Teledoc is also looking to expand internationally, Teladoc purchased Advance Medical in June 2018 which was the leading telehealth provider outside the US.
Teladoc Health Inc. shares plummeted as much as 20% in after-hours trading Wednesday after The online-health care company revealed that losses are expected to steepen in 2019 as revenue growth slows down. On the news the stock initial sold off.
Telemedicine represents a growing segment of the healthcare sector and telemedicine companies are reaping the benefits of its rising popularity. According to the Global Telemedicine Market Outlook 2020, published by RNCOS Consultancy, the global market for telemedicine technology was estimated at $26.5 billion for 2018, with a projected compound annual growth rate that should reach $41.2 billion in 2021.
Based on the mega shift to Telemedicine to cut medical cost and time, the chart suggest Teladoc could be a long term play if and when price gets to the monthly demand at $40.
This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.